Latest news articles tagged amb:Ambrilia Biopharma Inc.: Ambrilia Announces European Licensing Partnership with TEVA for its Lead Oncology Product, Octreotide» Market Wire - Pharmaceuticals and Biotech — 16th Nov 2006, 08:23
Ambrilia Biopharma Inc.: Ambrilia Announces Third Quarter 2006 Results and Provides Update on Lead Development ProgramsMarket Wire - Pharmaceuticals and Biotech — 14th Nov 2006, 14:16
|